A new study from the journal Biology of Sex Differences found an association between sex biases in drug dosage trials and the overmedication of women.
According to investigators, women are more likely than men to experience adverse drug reactions from medications, as clinical trials have historically focused on men.
In the August issue of Contemporary OB/GYN, Editor-in-Chief Dr. Catherine Y. Spong discussed the ways in which women’s health research has and continues to be marginalized. Read her full editorial here.
For additional details on the study’s findings, visit our sister publication, Drug Topics.
Personalized opioid protocol for cesarean deliveries: Reduced prescriptions reported
April 19th 2024A recent suggests that implementing a personalized opioid prescription protocol significantly reduces total morphine milligram equivalents and the number of opioid tablets prescribed at discharge following cesarean delivery.
Read More
Gender discrepancy found in ABCA4-associated retinopathy
April 18th 2024A recent meta-analysis suggests sex as a modifying factor in the development of ABCA4-associated retinopathy, revealing a higher proportion of women among individuals with a mild reduced penetrant ABCA4 variant, impacting prognosis predictions and recurrence risks.
Read More
Genetics associated with reproductive traits and uterine leiomyomata
April 17th 2024Investigating genetic correlations and shared loci sheds light on potential causal relationships between reproductive traits and uterine leiomyomata, offering insights into their complex interplay and urging further mechanistic exploration.
Read More